## Objective: To report the safety and efficacy of leflunomide (lef) in combination with infliximab (inf) for the treatment of rheumatoid arthritis. ## Methods: In an open, multicenter, retrospective study, data were collected on the safety and efficacy of lef and inf. ## Results: Eighty-eight
β¦ LIBER β¦
The side-effects and efficacy of leflunomide in Japanese patients with rheumatoid arthritis
β Scribed by KANBE, Katsuaki ;INOUE, Kazuhiko ;CHIBA, Junji ;NOGUCHI, Masahiko ;HIGUCHI, Yoriko ;MURATA, Minako
- Book ID
- 111241758
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 95 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0219-0494
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The safety and efficacy of leflunomide i
β
Hansen, K. E. ;Cush, J. ;Singhal, A. ;A. Cooley, D. ;Cohen, S. ;Patel, S. R. ;Ge
π
Article
π
2004
π
John Wiley and Sons
π
English
β 67 KB
π 2 views
Safety and effectiveness of leflunomide
β
Vlastimir Mladenovic; Zlatko Domljan; Blaz Rozman; Ivo Jajic; Dimitrije Mihajlov
π
Article
π
1995
π
John Wiley and Sons
π
English
β 844 KB
Clinical efficacy of abatacept in Japane
β
Takahashi, Nobunori; Kojima, Toshihisa; Terabe, Kenya; Kaneko, Atsushi; Kida, Da
π
Article
π
2012
π
Springer
π
English
β 381 KB
Leflunomide-induced interstitial lung di
β
Sawada, T.; Inokuma, S.; Sato, T.; Otsuka, T.; Saeki, Y.; Takeuchi, T.; Matsuda,
π
Article
π
2009
π
Oxford University Press
π
English
β 93 KB
Pharmacokinetics, safety, and efficacy o
β
Michael E. Weinblatt; Joel M. Kremer; Jonathan S. Coblyn; Agnes L. Maier; Simon
π
Article
π
1999
π
John Wiley and Sons
π
English
β 134 KB
π 2 views
The efficacy and safety of leflunomide i
β
J. R. Kalden; M. Schattenkirchner; H. SΓΆrensen; P. Emery; C. Deighton; B. Rozman
π
Article
π
2003
π
John Wiley and Sons
π
English
β 123 KB
π 2 views
## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, openβlabel extension of 2 phase III doubleβblind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t